Brian G. Lloyd, Chief Legal Officer and Secretary of Merit Medical Systems Inc, filed a Form 4 on November 17, 2026, disclosing the exercise of non-qualified stock options and a same-day sale of 16,722 shares of common stock on November 16, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Option exercise: Lloyd acquired 16,722 shares on November 16, 2026, by exercising non-qualified stock options at an exercise price of $37.71 per share.
  • Same-day sale: Lloyd disposed of 16,722 shares on November 16, 2026, at a weighted average price of $86.325, with individual transactions ranging from $85.88 to $86.90.
  • Remaining direct holdings: Following the transactions, Lloyd directly owned 60,132 shares of common stock, with an additional 2,000 shares held indirectly through a 401(k) plan.
  • 10b5-1 plan: Both the option exercise and the sale were effected pursuant to a Rule 10b5-1 trading plan adopted by Lloyd on May 21, 2026.
  • Remaining options: Lloyd retains non-qualified stock options covering a total of 31,351 shares across three outstanding grants with exercise prices of $56.25, $65.03, and $70.58.

Brian G. Lloyd's Option Exercise and Share Sale at Merit Medical Systems

According to the filing, Brian G. Lloyd, who serves as Chief Legal Officer and Secretary of Merit Medical Systems Inc (NASDAQ:MMSI), reported two transactions executed on November 16, 2026. Lloyd exercised non-qualified stock options covering 16,722 shares at an exercise price of $37.71 per share, with those options having become exercisable in equal annual installments of 25% commencing on February 26, 2021, and carrying an expiration date of February 26, 2027. Following the exercise, the derivative position was reduced to zero remaining options at that strike price.

On the same date, the filing discloses, Lloyd sold all 16,722 of those acquired shares. The price reported is a weighted average of $86.325, with transactions executed at prices ranging from $85.88 to $86.90, inclusive. The filing notes that Lloyd "undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4." Both the exercise and the sale were carried out under a Rule 10b5-1 trading plan that Lloyd adopted on May 21, 2026.

After the reported transactions, the filing states that Lloyd directly held 60,132 shares of Merit Medical Systems common stock. An additional 2,000 shares are reported as held indirectly through a 401(k) plan, with no transaction associated with that position. Lloyd also retains three separate non-qualified stock option grants covering 9,681 shares at $56.25, 8,094 shares at $65.03, and 13,576 shares at $70.58, each vesting in equal annual installments of 25% from their respective commencement dates.

What Was Disclosed

The filing reports that Lloyd exercised 16,722 options at $37.71 and sold the resulting shares at a weighted average of $86.325 on November 16, 2026, under a pre-established 10b5-1 plan, leaving him with 60,132 directly held shares.